Cyclic nucleotides, gut physiology and inflammation

Hari Prasad1, Avinash Ravindranath Shenoy2, Sandhya Srikant Visweswariah1

  • 1Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bengaluru, India.

The FEBS Journal
|January 1, 2020
PubMed

Insights

Pathogenic bacteria cause diarrhea by disrupting gut ion and water secretion via cyclic adenosine 3

Area of Science:

  • Gastroenterology
  • Microbiology
  • Cellular Biology

Background:

  • Diarrheal disease is a major global health concern, particularly in children.
  • Gut barrier erosion and inflammation are secondary effects of diarrhea.
  • Pathogenic bacteria contribute significantly to diarrheal diseases.

Purpose of the Study:

  • To investigate the role of cyclic nucleotides in pathogenic bacteria-mediated diarrhea.
  • To explore the impact of ion and water secretion on gut homeostasis.
  • To examine the potential modulation of inflammasome signaling by ion flux.

Main Methods:

  • Focus on pathogenic bacteria-mediated diarrhea.
  • Emphasis on cyclic adenosine 3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP) signaling pathways.
  • Speculation on ion flux effects on inflammasome signaling.

Main Results:

  • Cyclic nucleotides (cAMP and cGMP) drive signaling outputs leading to gut epithelial ion and water secretion.
  • Aberrant ion efflux and influx are implicated in diarrhea.
  • Potential modulation of inflammasome signaling by ion transport.

Conclusions:

  • Understanding cyclic nucleotide signaling is crucial for addressing bacterial diarrhea.
  • Ion transport dysregulation impacts gut barrier integrity and function.
  • Further research into ion flux and inflammasome interactions is warranted.

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
868
Physiology of Enteric Nervous System and Gut Health01:05

Physiology of Enteric Nervous System and Gut Health

The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
800
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
703
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
873
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
403
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K